All Information (Except Text) for S.2003 - FDA Cosmetic Safety and Modernization Act115th Congress (2017-2018)
|Sponsor:||Sen. Hatch, Orrin G. [R-UT] (Introduced 10/25/2017)|
|Committees:||Senate - Health, Education, Labor, and Pensions|
|Latest Action:||Senate - 10/25/2017 Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (All Actions)|
This bill has the status Introduced
Here are the steps for Status of Legislation:
There is 1 version of this bill. View text
Click the check-box to add or remove the section, click the text link to scroll to that section.
Titles Actions Overview All Actions Cosponsors Committees Related Bills Subjects Latest Summary All Summaries
Actions Overview (1)
|10/25/2017||Introduced in Senate|
10/25/2017 Introduced in Senate
All Actions (1)
|10/25/2017||Read twice and referred to the Committee on Health, Education, Labor, and Pensions.|
Action By: Senate
10/25/2017 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
|Committee / Subcommittee||Date||Activity||Reports|
|Senate Health, Education, Labor, and Pensions||10/25/2017||Referred to|
Subject — Policy Area:
One Policy Area term, which best describes an entire measure, is assigned to every public bill or resolution.
Latest Summary (1)
Introduced in Senate (10/25/2017)
FDA Cosmetic Safety and Modernization Act
This bill establishes a series of requirements relating to cosmetics regulation, including requiring cosmetics manufacturers and distributors to report serious adverse health events to the Food and Drug Administration.